With Knowledge Comes Confidence
Everything we know about the human body tells us that a lack of oxygen to the brain is a serious event with the potential for permanent, catastrophic consequences.
More than any other monitor of its kind, FORE‐SIGHT ELITE provides the confidence of knowing that your surgical patient is being accurately monitored in real time, so that hypoxic events have the best chance of being detected and treated immediately.
No one wants a catastrophic event to happen in their medical center, on their watch, and especially not to their patient. As cerebral oximetry advances toward becoming the standard of care, FORE‐SIGHT ELITE emerges as the obvious choice.
Consistently Ahead in Accuracy
FORE‐SIGHT is the most accurate cerebral oximeter in the world. Clinical comparison studies have consistently shown FORE‐SIGHT to be significantly more accurate than alternatives, with results that most closely correlate with the products original validation. A device that delivers a number this accurate gives the clinician the best insight into their patient’s oxygenation, empowering the medical and surgical teams to intervene – or decide not to – with confidence.
Much more than a catastrophic event detector, FORE‐SIGHT is an essential anesthesia management tool, backed by clinical validation that is complete, thorough and robust.
The data in these graphs was reported in Bickler PE, Feiner JR, Eilers H, Rollins M. “Performance of 5 cerebral oximeters during hypoxia in healthy volunteers.” Proceedings of the 2011 Annual Meeting of the American Society of Anesthesiologists; Abstract LBT07.
Select button below to see accuracy of each model.
Utilizing cerebral oximetry in your OR isn’t free – but when you consider the alternative, it’s a nominal expense. The value of cerebral oximetry, especially FORE-SIGHT, is best measured by the cost of not using it.
We all know that the cost of an undetected catastrophic hypoxic event can be loss of life, permanent disability and a lifetime of regret, but studies have shown that even relatively less serious hypoxic events may lengthen the duration on mechanical ventilation, time spent in the ICU, or in overall hospital length of stay.
When better monitoring contributes to better patient care and therefore outcomes, more often than not – hospitals experience a better bottom line.
FINANCIAL ANALYSIS TOOL
Skeptics, Take Another Look
If you are skeptical about cerebral oximetry, the accuracy, reliability, and performance of FORE-SIGHT ELITE make it time for another look.
All medical professionals understand that brain tissue is highly vulnerable to oxygen deprivation during cardiac and other surgeries. Other monitoring methods like pulse oximetry only allow clinicians to infer cerebral oxygenation. Cerebral oximetry is the only non‐invasive organ-specific monitoring parameter to specifically determine whether or not the brain is properly oxygenated.
Early cerebral oximeter technology probably arrived before it was ready for prime time. The first monitors were strikingly less accurate and reliable than today’s technology – and not at all intuitive to use. For many who used those early devices, the performance (or lack thereof) still influences a negative perception of the technology. There is no longer a need to infer what is happening based on watching (and remembering) trends over time.
FORE-SIGHT reimagined and set new standards for the technology in collaboration with many of the brightest minds in anesthesiology. In doing so, FORE-SIGHT has significantly advanced cerebral oximetry toward the standard of care in ORs around the world. Moreover, the FORE-SIGHT team continues to improve and innovate the technology, increasing its clinical utility.
FORE-SIGHT’s unparalleled accuracy gives you the confidence of knowing – knowing that your patient’s brain is protected, knowing that your intervention is warranted, knowing that the number on the screen means something.
FORE‐SIGHT ELITE technology has been shown to provide patient readings that have a range of variation of approximately +/‐ 3.05 percent to the reference value at one Standard Deviation. In other words, at only 3.05% above or below the true StO2 value, FORE-SIGHT consistently provides the best picture of the patient’s actual cerebral oxygen status when compared to all other commercially-available cerebral oximeters.
With the most commonly found oximeter’s variation at almost +/- 10% at one Standard Deviation, it is no wonder why some have yet to see the value of cerebral oximetry. A 10% variation in StO2 is often the difference between a patient coping well with small and minor changes in cerebral oxygen status and a patient in need of immediate intervention – how can you tell the difference?
If you had a less-than-rewarding experience with early cerebral oximetry devices or the one you are currently using, it is time to take another look at FORE-SIGHT, the industry leader in accuracy, precision, and overall product performance.